National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
118.86
+1.05 (0.89%)
Oct 8, 2025, 1:57 PM EDT - Market open
National HealthCare Market Cap
National HealthCare has a market cap or net worth of $1.84 billion as of October 8, 2025. Its market cap has decreased by -5.77% in one year.
Market Cap
1.84B
Enterprise Value
1.76B
1-Year Change
-5.77%
Ranking
Category
Stock Price
$118.86
Market Cap Chart
Since December 1, 1998, National HealthCare's market cap has increased from $188.20M to $1.84B, an increase of 878.98%. That is a compound annual growth rate of 8.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 1.83B | 9.96% |
Dec 31, 2024 | 1.66B | 17.26% |
Dec 29, 2023 | 1.42B | 55.13% |
Dec 30, 2022 | 913.00M | -12.87% |
Dec 31, 2021 | 1.05B | 2.74% |
Dec 31, 2020 | 1.02B | -22.96% |
Dec 31, 2019 | 1.32B | 10.79% |
Dec 31, 2018 | 1.20B | 29.04% |
Dec 29, 2017 | 926.10M | -19.34% |
Dec 30, 2016 | 1.15B | 24.85% |
Dec 31, 2015 | 919.70M | 3.82% |
Dec 31, 2014 | 885.90M | 16.84% |
Dec 31, 2013 | 758.20M | 15.32% |
Dec 31, 2012 | 657.50M | 13.44% |
Dec 30, 2011 | 579.60M | -7.74% |
Dec 31, 2010 | 628.20M | 27.14% |
Dec 31, 2009 | 494.10M | -24.92% |
Dec 31, 2008 | 658.10M | 1.53% |
Dec 31, 2007 | 648.20M | -4.59% |
Dec 29, 2006 | 679.40M | 48.44% |
Dec 30, 2005 | 457.70M | 11.07% |
Dec 31, 2004 | 412.10M | 78.17% |
Dec 31, 2003 | 231.30M | 17.23% |
Dec 31, 2002 | 197.30M | 14.91% |
Dec 31, 2001 | 171.70M | 99.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 757.36B |
Johnson & Johnson | 454.91B |
AbbVie | 411.31B |
UnitedHealth Group | 329.36B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 231.52B |